KEWAUNEE SCIENTIFIC CORP /DE/ - Common Stock, $2.50 par value per share (KEQU)
CUSIP: 492854104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $2.50 par value per share
- Shares outstanding
- 2,867,364
- Total 13F shares
- 955,059
- Share change
- +20,397
- Total reported value
- $44,998,960
- Price per share
- $47.20
- Number of holders
- 27
- Value change
- +$985,967
- Number of buys
- 17
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 492854104?
CUSIP 492854104 identifies KEQU - KEWAUNEE SCIENTIFIC CORP /DE/ - Common Stock, $2.50 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 492854104:
Top shareholders of KEQU - KEWAUNEE SCIENTIFIC CORP /DE/ - Common Stock, $2.50 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NORTHERN TRUST CORP |
13F
|
Company |
10%
|
294,297
|
$10,123,817 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
6%
|
171,416
|
$5,836,715 | — | 31 Mar 2024 | |
| Minerva Advisors LLC |
13F
|
Company |
5%
|
144,582
|
$4,886,871 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
122,145
|
$4,201,788 | — | 31 Mar 2024 | |
| David S. Rhind |
3/4/5
|
Director |
—
class O/S missing
|
132,992
|
$3,848,789 | — | 01 Jul 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.8%
|
79,031
|
$2,719,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
30,400
|
$1,035,120 | — | 31 Mar 2024 | |
| De Lisle Partners LLP |
13F
|
Company |
0.95%
|
27,258
|
$930,996 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.84%
|
24,090
|
$828,696 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
17,948
|
$611,310 | — | 31 Mar 2024 | |
| Kurt P. Rindoks |
3/4/5
|
VP - Global Prod Development |
—
class O/S missing
|
14,986
|
$433,695 | — | 26 Aug 2022 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.28%
|
8,033
|
$276,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.28%
|
7,970
|
$274,168 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.23%
|
6,483
|
$220,000 | — | 31 Mar 2024 | |
| Lisa L. Ryan |
3/4/5
|
VP-Construction/Cust. Servs. |
—
class O/S missing
|
1,817
|
$52,584 | — | 08 Jul 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.02%
|
500
|
$17,200 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
416
|
$14,310 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
56
|
$2,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
32
|
$1,090 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
18
|
$603 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
5
|
$170 | — | 31 Mar 2024 |
Institutional Holders of KEWAUNEE SCIENTIFIC CORP /DE/ - Common Stock, $2.50 par value per share (KEQU) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.